Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study

Wei-Chen Lin, Jen-Wei Chou, Hsu-Heng Yen, Wen-Hung Hsu, Hung-Hsin Lin, Jen-Kou Lin, Chiao-Hsiung Chuang, Tien-Yu Huang, Horng-Yuan Wang, Shu-Chen Wei, Jau-Min Wong

Intest Res. 2017;15(4):487-494. Published online October 23, 2017
DOI: https://doi.org/10.5217/ir.2017.15.4.487

Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study

Wei-Chen Lin, Jen-Wei Chou, Hsu-Heng Yen, Wen-Hung Hsu, Hung-Hsin Lin, Jen-Kou Lin, Chiao-Hsiung Chuang, Tien-Yu Huang, Horng-Yuan Wang, Shu-Chen Wei, Jau-Min Wong

Intestinal Research. 2017;15(4):487

Link1 Link2 Link3

Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study

Chen-Wang Chang, Shu-Chen Wei, Jen-Wei Chou, Tzu-Chi Hsu, Chiao-Hsiung Chuang, Ching-Pin Lin, Wen-Hung Hsu, Hsu-Heng Yen, Jen-Kou Lin, Yi-Jen Fang, Horng-Yuan Wang, Hung-Hsin Lin, Deng Cheng Wu, Yen Hsuan Ni, Cheng-Yi Wang, Jau-Min Wong

Intestinal Research. 2014;12(4):287

Link1

Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease

Wael El-Matary

Crohn's & Colitis 360. 2019;1(3):

Link1

Link2

Link3

Classification of Crohn's Disease and Inflammatory Bowel Disease Surgery-Related Fistulae

Amy L. Lightner

Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018;111-118

Link1 Link2

Is Surgery the Best Initial Treatment for Limited Ileocecal Crohn's Disease?

Tom øresland

Clinical Dilemmas in Inflammatory Bowel Disease. 2011;175-177

Link1

Classification of Strictures From Crohn's Disease, Ulcerative Colitis, and Inflammatory Bowel Disease–Related Surgery

Bo Shen

Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. 2018;97-109

Link1 Link2

Long-Term Outcomes of Proactive Therapeutic Drug Monitoring of Adalimumab and Standard of Care in Patients With Inflammatory Bowel Disease

Cong Dai, Min Jiang, Ji-hong Yu

Journal of Crohn's and Colitis. 2019;13(8):1092-1093

Link1

Medical treatment of moderate to severe Crohn's disease

M. Scribano, C. Prantera

Alimentary Pharmacology & Therapeutics. 2003;17:23-30

Link1 Link2 Link3

P411 Faecal calprotectin is more tightly associated with endoscopic disease activity compared with other biomarkers in patients with inflammatory bowel disease under maintenance treatment with adalimumab

E Orfanoudaki, E Theodoraki, K Foteinogianopoulou, A Mantaka, I Koutroubakis

Journal of Crohn's and Colitis. 2020;14(Supplement_1):S377-S377

Link1

Link2

P392 Body mass index has no effect on treatment response in Crohn's disease patients with moderate disease activity who receive adalimumab

K Soufleris, K Fasoulas, N Kafalis, G Lazaraki, D Tzilves

Journal of Crohn's and Colitis. 2019;13(Supplement_1):S304-S304

Link1